Efficacy Study of Telbivudine in Chronic Hepatitis B Patients

Clinical trial NCT01958229 · COMPLETED

Trial details

NCT number: NCT01958229
Sponsor: National Taiwan University Hospital
Status: COMPLETED
Study type: OBSERVATIONAL

Chronic Hepatitis B Roadmap Concept in Chronic Hepatitis B Treatment 24-week PCR Negativity of Telbivudine PCR Negativity at 52 and 104 Week HBeAg Seroconversion Rate at 52 and 104 Week

Start date: 2009-12-01
Primary completion: 2012-03-01
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.